VXL.V Stock - Vaxil Bio Ltd.
Unlock GoAI Insights for VXL.V
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | $-2,000 | $-25,000 | $-57,000 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-196,000 | $-254,000 | $-584,000 | $-986,000 | $-1,347,000 |
| Net Income | $-178,000 | $-254 | $-584,000 | $-986,000 | $-1,358,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.00 | $0.00 | $-0.00 | $-0.01 | $-0.01 |
Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company's lead product is ImMucin that has completed a Phase I/II clinical trial for the treatment of multiple myeloma. It is also developing a tuberculosis vaccine/treatment and a coronavirus (COVID-19) vaccine. The company has a collaboration agreement with The Tel Aviv Sourasky Medical Center for the company's research program to develop a potential peptide vaccine against COVID-19; and cooperative research and development agreement with U.S. Army Medical Research Institute of Infectious Diseases for testing CorVax for its ability to prevent COVID-19 in mice. The company was founded in 2006 and is headquartered in Toronto, Canada.
Visit WebsiteEarnings History & Surprises
VXL.VEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 27, 2025 | — | $-0.01 | — | — |
Q3 2025 | Aug 28, 2025 | — | $0.02 | — | — |
Q2 2025 | May 27, 2025 | — | $-0.00 | — | — |
Q2 2025 | Apr 24, 2025 | — | $-0.00 | — | — |
Q4 2024 | Nov 27, 2024 | — | $-0.00 | — | — |
Q3 2024 | Aug 28, 2024 | — | $-0.00 | — | — |
Q2 2024 | Jun 30, 2024 | — | $-0.00 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.00 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.00 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.00 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.00 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.00 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.00 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.00 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.00 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.00 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.00 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.01 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.00 | — | — |
Latest News
Frequently Asked Questions about VXL.V
What is VXL.V's current stock price?
What is the analyst price target for VXL.V?
What sector is Vaxil Bio Ltd. in?
What is VXL.V's market cap?
Does VXL.V pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to VXL.V for comparison